District of Columbia Administrative Code

6402 TESTING LABORATORY LICENSE APPLICATION 6402.1 In addition to the requirements contained in the Act and other provisions of this title, an application for a testing laboratory license shall also contain the following: (a) A laboratory testing plan that demonstrates the applic…

6404 ACCREDITATION, CERTIFICATION AND INSPECTION 6404.1 A testing laboratory registrant shall be accredited pursuant to standard ISO/IEC 17025 of the International Organization for Standardization by a nonprofit, impartial organization that operates in conformance with standard I…

6405 RECORDS RETENTION 6405.1 A testing laboratory shall create, and maintain for not less than five (5) years, and make them immediately available to the Board upon request, records of the testing it conducted on medical cannabis and medical cannabis products, which shall includ…

6406 LABORATORY PERSONNEL QUALIFICATIONS AND DUTIES 6406.1 All testing laboratory personnel shall be registered with the Board. 6406.2 All testing laboratory personnel shall: (a) Pass a criminal background check pursuant to § 5411 of this subtitle; and (b) Sign an attestation sta…

6407 [REPEALED] SOURCE: Final Rulemaking published at 66 DCR 10217 (August 9, 2019); as amended by Final Rulemaking published at 71 DCR 002388 (March 8, 2024); as amended by Final Rulemaking published at 73 DCR 002136 (February 20, 2026). District of Columbia Municipal Regulation…

6409 [REPEALED] SOURCE: Final Rulemaking published at 66 DCR 10217 (August 9, 2019); as amended by Final Rulemaking published at 71 DCR 002388 (March 8, 2024); as amended by Final Rulemaking published at 73 DCR 002136 (February 20, 2026). District of Columbia Municipal Regulation…

6410 [REPEALED] SOURCE: Final Rulemaking published at 66 DCR 10217 (August 9, 2019); as amended by Final Rulemaking published at 71 DCR 002388 (March 8, 2024); as amended by Final Rulemaking published at 73 DCR 002136 (February 20, 2026). District of Columbia Municipal Regulation…

6500 MEDICAL CANNABIS TESTING REQUIREMENT 6500.1 Upon the issuance of a testing laboratory license, ABCA shall provide notice in the District of Columbia Register that a testing lab has become operational and that the testing requirement is in effect. 6500.2 Once notice of the is…

6501 STANDARD OPERATING PROCEDURE REQUIREMENTS 6501.1 A testing laboratory shall have a written manual of standard operating procedures, with detailed instructions for performing each testing method the testing laboratory uses and the minimum standards for each test. The written …

6502 TESTING REQUIREMENTS AND METHODOLOGIES 6502.1 Each testing laboratory shall: Follow the most current version of the “Cannabis Inflorescence: Standards of Identity, Analysis, and Quality Control” monograph published by the American Herbal Pharmacopoeia; (b) Follow the most cu…

6503 CREATION OF BATCHES 6503.1 A cultivation center or manufacturer shall divide medical cannabis or medical cannabis products into homogenous batches not to exceed 50 pounds, and as directed by a testing laboratory. 6503.2 A cultivation center or manufacturer shall divide medic…

6504 SAMPLE REQUIREMENTS FOR MEDICAL CANNABIS 6504.1 With the exception of pre-rolled medical cannabis, all cannabis and cannabis products must be in final form ready to be packaged upon receipt of passing results for all required tests to be sampled. 6504.2 A cultivation center …

6505 PACKAGING OF SAMPLES FOR TESTING 6505.1 All samples of cannabis or cannabis products must be transferred to a testing facility in sealed, child-resistant, and tamper-evident containers that are supplied by a testing facility or that meet criteria specified by a testing facil…

6506 TESTING FOR RESIDUAL SOLVENTS 6506.1 Cultivation centers and manufacturers shall test all products for residual solvents and processing chemicals in accordance with this section before distributing, selling, or otherwise transferring the product to an internet retailer, manu…

6507 TESTING FOR MYCOTOXIN 6507.1 Cultivation centers and manufacturers shall test all products for mycotoxin in accordance with this section before distributing, selling, or otherwise transferring the product to an internet retailer, manufacturer, or retailer. 6507.2 The testing…

6508 TESTING FOR FOREIGN MATERIAL 6508.1 Cultivation centers and manufacturers shall test all products for mold, mildew, pests, and other foreign materials in accordance with this section before distributing, selling, or otherwise transferring the product to an internet retailer,…

6509 TESTING FOR FERTILIZER AND NUTRIENTS 6509.1 Cultivation centers and manufacturers shall test all products for the presence and concentration of fertilizer and nutrients in accordance with this section before distributing, selling, or otherwise transferring the product to an …

6511 RESULT REPORTING 6511.1 A testing laboratory shall issue results for each sample tested which shall address the following: (a) Whether the chemical profile of the medical cannabis sample conforms to the accepted variety for the following compounds: (1) Delta-9-tetrahydrocann…

6600 PROHIBITION ON DISTRIBUTING ADULTERATED PRODUCTS 6600.1 Medical cannabis and medical cannabis products that exceed, fail, or violate any of the testing standards, testing limits, or testing levels provided by the Act or this chapter shall be deemed adulterated and unfit for …

6700 COURIERS 6700.1 A courier shall not obtain medical cannabis or medical cannabis product except when: (a) Fulfilling an order submitted by a qualifying patient or caregiver, on behalf of a licensed internet retailer or retailer; or (b) Obtaining medical cannabis in their pers…

700 ISSUANCE OF REGISTRATION CARDS Upon receipt and approval of a valid and complete application, the Board shall issue a registration identification card to a qualifying patient or caregiver in accordance with the Act and this subtitle. 700.2 A registration identification card i…

701 CONTENTS OF REGISTRATION CARDS 701.1 A qualifying patient registration identification card shall contain: (a) The date of issuance and expiration date; (b) The qualifying patient’s full, legal name, and the full, legal name of the patient’s caregiver, if applicable; (c) The r…

702 RENEWAL OF REGISTRATION CARDS Not later than sixty (60) days prior to the expiration of a registration identification card, the qualifying patient or caregiver may apply for renewal of their registration identification card as follows: Submit a completed renewal application t…

800 QUALIFICATIONS TO BE A RECOMMENDING AUTHORIZED PRACTITIONER 800.1 An authorized practitioner who is licensed and in good standing to practice medicine, osteopathy, advanced practice registered nursing, dentistry, naturopathic medicine, or as a physician assistant in the Distr…

801 FORM OF RECOMMENDATION 801.1 An authorized practitioner’s recommendation that a qualifying patient may use medical cannabis shall be written on a form provided by the Board and include the following: (a) The name, address, telephone number, and specialty or primary area of cl…

802 RECORDS MAINTAINED BY AUTHORIZED PRACTITIONERS AND BOARD 802.1 An authorized practitioner recommending the use of medical cannabis to a qualifying patient shall maintain a record for each qualifying patient which shall: (a) Accurately reflect the evaluation and treatment of t…

803 PROHIBITED OFFICE LOCATIONS 803.1 An authorized practitioner recommending the use of medical cannabis to a qualifying patient shall not: Have a professional office located at or adjacent to an internet retailer or retailer, cultivation center, or testing laboratory; Have empl…

804 NOTIFICATION OF END OF QUALIFYING MEDICAL OR DENTAL CONDITION OR TREATMENT 804.1 An authorized practitioner shall notify the Board in writing within fourteen (14) calendar days after advising a qualifying patient that he or she no longer suffers from a qualifying medical or d…

805 [REPEALED] SOURCE: Emergency and Third Proposed Rulemaking published at 58 DCR 3299 (April 15, 2011)[EXPIRED]; as amended by Emergency and Fourth Proposed Rulemaking published at 58 DCR 7207 (August 12, 2011)[EXPIRED]; as amended by Final Rulemaking published at 58 DCR 10128,…

806 [REPEALED] SOURCE: Final Rulemaking published at 65 DCR 3926 (April 13, 2018); as amended by Final Rulemaking published at 71 DCR 002388 (March 8, 2024). District of Columbia Municipal Regulations Medical Marijuana 22-C DCMR § 806 AUTHORITY: DC-DCMR Section 14 of the Legaliza…

807 TELEHEALTH MEDICINE Authorized practitioners may provide telehealth medicine services to qualifying patients, including recommending the use of medical cannabis in accordance with this title, consistent with the laws and regulations governing their medical practice. For purpo…

900 DENIAL OF APPLICATIONS FOR PATIENT AND CAREGIVER REGISTRATIONS The Board may deny an application or renewal application for a qualifying patient or caregiver registration identification card only if: The application is incomplete and the applicant fails to provide the missing…

9600 ESTABLISHMENT OF MORATORIUM 9600.1 If the Board reasonably determines that it is in the public interest to do so based on the standards set forth in the Act, the Board may, by rule: (a) Limit the number of medical cannabis business licenses of any class to be issued; or (b) …

9601 MORATORIUM PROCEDURES 9601.1 The moratorium request shall be made to the Board in writing, providing: (a) The identity of the ANC; (b) The resolution containing the official ANC vote and statement approving of the moratorium request filed with the Board; (c) The area of the …

9602 MORATORIUM NOTICE 9602.1 If a moratorium request meets all the requirements set forth in this chapter, the Board shall provide notice to the public according to the same procedures as required by § 5425. SOURCE: Final Rulemaking published at 73 DCR 002136 (February 20, 2026)…

9603 MORATORIUM HEARING 9603.1 The Board shall hold a public hearing to review a proposed moratorium. The public hearing shall be a rulemaking hearing under section 6 of the DC APA and not in the nature of a contested case under section 10 of the DC APA. 9603.2 At the public hear…

9700 HEARING PROCEDURES - APPLICABILITY 9700.1 This chapter shall apply to all hearings held before the Board, including: (a) Roll call hearings or status hearings regarding the issuance, transfer, or renewal of a license, or the making of substantial changes to a licensee’s busi…

9701 CONTINUANCES 9701.1 A hearing may be continued for good cause. 9701.2 A written motion for a continuance shall be filed with the Board at least six (6) calendar days before the scheduled hearing date and served upon all parties at least six (6) calendar days before the heari…

9702 WITNESSES 9702.1 A party shall have the right to call and examine witnesses. 9702.2 Except as provided in § 9702.3, at any proceeding before the Board in a contested case, the Board may hear as witnesses all persons residing within and outside the neighborhood who desire to …

9703 RULE ON WITNESSES 9703.1 At the request of a party, or on its own motion, the Board shall order witnesses excluded so that they will not hear the testimony of other witnesses. 9703.2 The following persons shall not be excluded from hearings before the Board: (a) The applican…

9704 EXAMINATION OF WITNESSES 9704.1 In any proceeding before the Board, each party shall have the right to present in person or by counsel or designated representative, the party’s case or defense, including oral and documentary evidence, to submit rebuttal evidence, and to cros…

9705 PARTIES, INTERVENTION, AND RIGHT TO BE HEARD 9705.1 The parties to a show cause hearing shall be the following: (a) The respondent, licensee, permittee, or applicant; and (b) The District of Columbia. 9705.2 The parties to a protest hearing shall be the applicant and the pro…

9706 COMPUTATION OF TIME FOR FILINGS 9706.1 Whenever a party to a proceeding under this chapter has the right or is required to perform some act within a specified time period after the service of notice upon the party, and the notice is served upon that party by mail, three (3) …

9707 SERVICE OF PAPERS 9707.1 Any papers filed with the Board or on opposing parties in a contested case shall be served by personal delivery, first class U.S. mail, registered or certified mail, or by electronic mail. Proof of service shall be shown as required by the regulation…

9708 APPEARANCE AND REPRESENTATION 9708.1 An individual may represent himself or herself in any proceeding before the Board. 9708.2 An attorney may represent any party before the Board by submitting a Notice of Appearance or completing ABCA’s Attorney/Representative Designation F…

9709 NOTICE OF APPEARANCE 9709.1 A non-lawyer representative shall submit a signed statement containing that person’s name, address, e-mail address, telephone number, and the nature of the representation, or ABCA’s Attorney/Representative Designation Form prior to appearing befor…

9710 SCHEDULING AND CONDUCT OF HEARINGS: GENERAL PROVISIONS 9710.1 The Board shall not schedule any hearing until the applicant has submitted, in writing to the Board, all information and documents required by the Act and the regulations. 9710.2 Before a person may be heard to ob…

9711 EVIDENCE: GENERAL RULES 9711.1 Any party objecting to the admission of evidence shall state the grounds relied upon for the objection. 9711.2 Formal exceptions to the rulings of the Board made during the course of a hearing shall not be required. 9711.3 The parties may, by s…

9712 BURDEN OF PROOF 9712.1 In all protest hearings before the Board, the applicant shall have the burden of proof to show by substantial evidence in the record that the licensing action meets the appropriate standards in accordance with this title. 9712.2 In all show cause proce…

9713 OPENING AND CLOSING STATEMENTS 9713.1 In all protest hearings before the Board, the applicant shall open and close the case insofar as presentation of evidence and argument are concerned. 9713.2 In all show cause proceedings before the Board, the District of Columbia shall o…